Freddie Dear

Freddie Dear is an accomplished professional in the biotechnology and investment sectors, currently serving as Principal at Monograph Capital and Strategic Advisor at Ascend Advanced Therapies. Freddie holds the position of Investor Director at Nocion Therapeutics, Inc. and has previously occupied key roles such as VP of Corporate Development and Head of Corporate Development & Portfolio Manager at Ascend Advanced Therapies. Additional experience includes Board Observer positions at Clade Therapeutics, Forcefield Therapeutics, and Quell Therapeutics, as well as an Investment Partner role at Syncona Limited. Freddie began the professional journey with a Finance and Investment graduate role at Wellcome Trust after completing a Bachelor of Science in Biochemistry at The University of Edinburgh.